FDA Adverse Event Injury Summary report: N

XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 10362203 · Received August 4, 2020

Report

Report Number
2024168-2020-06477
Event Type
Injury
Date Received
August 4, 2020
Date of Event
March 26, 2019
Report Date
August 4, 2020
Manufacturer
ABBOTT VASCULAR
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019, THE PATIENT PRESENTED WITH A DISTAL LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY, 99% STENOSED LESION. PRE-DILATATION WAS PERFORMED AND A 2.75X33MM XIENCE SIERRA STENT (1500275-33, 8082141) WAS IMPLANTED. STENT PLACEMENT WAS DEEMED ACCEPTABLE WITH 0% RESIDUAL DIAMETER STENOSIS, TIMI FLOW III, AND NO COMPLICATIONS. POST-PROCEDURE THAT SAME DAY, ELEVATED TROPONIN WAS OBSERVED. ANOTHER TROPONIN WAS DRAWN WITH THE RESULTS TRENDED DOWNWARD. REPORTEDLY, THE EVENT WAS SERIOUS AS PROLONGED HOSPITALIZATION WAS REQUIRED. THERE WAS NO NEW MYOCARDIAL INFARCTION DIAGNOSED, NO TREATMENT REQUIRED, AND THERE WAS NO DEVICE MALFUNCTION. THE EVENT RESOLVED WITHOUT SEQUELA AND THE PATIENT WAS DISCHARGED HOME THE FOLLOWING DAY, (B)(6) 2019. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
826691 XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT DELIVERY SYSTEM NIQ ABBOTT VASCULAR 8082141

Patients

Seq Age Sex Outcome Treatment
1 62 YR Hospitalization